Information about vaccines and the COVID-19 situation in Finland

COVID-19 affects us all and like many across Europe, we are still counting the devastating human and economic cost of this pandemic. We share the desire to get safe and effective vaccines to as many people as possible, as quickly as possible.


The new Chair of the Board of Pharma Industry Finland (PIF), Mr Matthew Iles, wishes to build up closer cooperation

PIF’s new Chair of the Board, Mr Matthew Iles, says that the crises will be solved, the challenges in healthcare will be met and the economic situation in our society will be coped with only by building up good cooperation.


Nanoform as a new member of PIF

Nanoform, an innovative nanoparticle medicine enabling company based in Helsinki, has been accepted as a new member of Pharma Industry Finland (PIF) by the Board of our association.

18.10.2019 | Mia Bengtström, Senior Advisor, Pharma Industry Finland

3rd Nordic Conference on Pediatric Medicines - promoting pediatric research through collaboration and new ideas

During the conference we discussed the EU Pediatric Regulation (EC 1901/2006) and the ways to improve the health of the children in Europe by increasing the research and authorization of medicines for children and improving the information on medicines designed for children.

18.10.2019 | Emma Hannonen, Senior Advisor, Pharma Industry Finland

Smart Health Forum in the European Parliament

PIF organized on Tuesday 15th October the Smart Health Forum in the European Parliament in Brussels. The event was organized together with the Swedish and Danish associations as well as with EK (Confederation of Finnish Industries) and EFPIA.

1 2 3 4 5 6 7